MorganAsh

Video script

For many UK businesses, funding a defined benefit pension scheme is a financial headache.

Not only can their balance sheets accumulate deficits, they may also pay more into schemes than is needed.

Why?

The value of a pension scheme is estimated by actuaries – using a set of standard, but broad-brush, assumptions. Postcodes are often used as a measure of scheme members’ health – and therefore how long they will live. While not total guesswork, the resulting figures are rarely accurate.

Because they’re accepted as the only statistics available, assumption-based mortality estimates have been used for years. But, with the advent of medical underwriting, this no longer needs to be true. 

Assessing scheme members’ actual health provides a far closer prediction of longevity; one which significantly affects the overall scheme value. Medical underwriting studies typically find that previous valuations can be 5% to 10% higher than needed.

Medical underwriting isn’t revolutionary. It’s regulator-approved and has won industry awards. It’s been used on thousands of pension schemes. It has enabled billions of pounds’ worth of pensions to be revalued empirically, saving companies millions – and significantly reducing pension-based risk.

The company delivering these improvements is MorganAsh.

MorganAsh replaces assumptions with evidence – authentic personal health information, gathered sensitively and securely by medical professionals.

Every medically underwritten mortality study undertaken by MorganAsh has led to a scheme revaluation – 99% of which were lower than previous estimates.

Medically underwritten mortality studies aren’t rocket science. But they are smart.

Medically underwritten mortality studies from MorganAsh.

Medically underwritten mortality studies

If you are interested in medically underwritten mortality studies, please get in touch. We’ll be happy to help.


Our clients say:

I would comment that I am extremely pleased with the handling of this application from submission to the confirmation of acceptance within a time span of ten days. It clearly demonstrated the efficiency of the telephone interview process which in this case took place within a few days of receipt of the application. I feel that particularly where the applicant is female it is more satisfactory for the client to discuss health and medical background issues as the client feels more comfortable talking to a ‘neutral’ person. Additionally, it takes the responsibility off the intermediary in the knowledge that any non-disclosure does not rest with him/her. I did ask my client in this particular case how she felt about the tele-interview and received a very positive response confirming her entire satisfaction with the process. Thanks, and ‘well done’.

An independent financial adviser